ImmunoPET in Multiple Myeloma-What? So What? Now What?

Bailly, C; Chalopin, B; Gouard, S; Carlier, T; Remaud-Le Saec, P; Marionneau-Lambot, S; Moreau, P; Touzeau, C; Kraeber-Bodere, F; Bodet-Milin, C; Cherel, M

Cherel, M (corresponding author), Univ Nantes, Univ Angers, CNRS, CRCINA,INSERM, F-44093 Nantes, France.; Cherel, M (corresponding author), ICO Rene Gauducheau Canc Ctr, Dept Nucl Med, F-44800 St Herblain, France.

CANCERS, 2020; 12 (6):

Abstract

Despite constant progress over the past three decades, multiple myeloma (MM) is still an incurable disease, and the identification of new biomarkers t......

Full Text Link